N,N-Dimethyl-1-(1H-pyrrolo[2,3-b]pyridin-3-yl)methanamine, 97.0%, 1g

(S)-3-methyl-2-phenylbutan-1-amine, 98%, 250mg

4-[2-(4-methoxyphenyl)acetyl]-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

5-Cyclopropyl-1H-pyrazole, 95.0%, 25g

3-(Bromomethyl)phenol, 95.0%, 1g

2,3-Dichloro-5-(difluoromethyl)pyridine, 97%, 100mg

(1S,2S)-N1,N2-BIS(2-(BIS(3,5-DIMETHYLPHENYL)PHOSPHINO)BENZYL)CYCLOHEXANE-1,2-DIAMINE, 95%, 100mg

Ethylene Glycol Monoallyl Ether>98.0%(GC)500mL

ethyl 5-oxo-5-[4-(piperidinomethyl)phenyl]valerate, 97.0%, 1g

3-(Boc-amino)-3-methyl-1-butanol, 95%, 25g

Diluyente nitro, tec., 1 l, bl.

Ethyl 4-methyl-4H-pyrrolo[2,3-d][1,3]thiazole-5-carboxylate, 98%, 5g

1-(azetidin-3-yl)-3-fluoropyrrolidine dihydrochloride, 95.0%, 250mg